Pfizer Inc
NYSE: PFE
$26.31
+$0.26 (+1.0%)
Closing Price on March 18, 2025
PFE Articles
Dividends are still rising and equity and income investors should expect more of the same for 2012. The Walt Disney Company (NYSE: DIS) joined in on the dividend hike brigade with another dividend...
Published:
Last Updated:
The EU continues to work on its bailout fund and may ask the IMF for help. (Reuters) American Airlines parent AMR (NYSE: AMR) files for Chapter 11. (Reuters) S&P cuts its ratings on large...
Published:
Pfizer Inc. (NYSE: PFE) has a big day ahead of it. While it has been known for years, it is a massive date: Lipitor goes off-patent and will have generic versions of the statin drug competitors....
Published:
It now costs about $1 billion to get a new drug to market, or, if a company is unlucky, $1 billion to fail to get the drug to market. Like the movie business, a drug company tries to develop that...
Published:
The supercommittee appears unlikely to settle on a deficit agreement. (Reuters) A senior Chinese official says he expects the global recession to last for some time. (Reuters) Spain’s center-right...
Published:
Some companies just want to keep bringing on new share buybacks whether they work or not. Some are to stop dilution from acquisitions or employee stock options, while others are to reduce the float...
Published:
The economic choppiness is coming to a head with the age of dividend hikes. The pressure is going to remain for companies to continue returning capital to shareholders while also looking for...
Published:
Last Updated:
George Papandreou convinces the Greek cabinet of the virtues of a national referendum on budget cuts, but he now faces the leaders of France and Germany. (Reuters) The FBI may investigate the fall of...
Published:
The markets are beyond jittery. From a massively overbought market discounting a recession entirely back to a market dominated by the woes of Europe. The Europeans cannot get their bailouts...
Published:
Last Updated:
Earnings season is still running strong and the economic readings keep coming out as well. As we come to the end of October, there is going to be plenty of news coming down the pipe. We also have...
Published:
Last Updated:
Short sellers moved out of stocks that have fallen recently. Perhaps they believe there will be a large rally in the market. There is little else to make the shares of companies with poor earnings...
Published:
Novartis (NYSE: NVS) said it would cut 2,000 workers and outsource some functions to companies that will do the work for less than it can. Novartis will take a restructuring charge of $300 million....
Published:
A company can spend billions of dollars on R&D and get little respect as an innovator. Even though that is the conclusion of a new study by Booz & Co., the conclusion is misleading. Booz...
Published:
Our expert who first called NVIDIA in 2009 is predicting 2025 will see a historic AI breakthrough.
You can follow him investing $500,000 of his own money on our top AI stocks for free.